Department of Clinical Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, Fukuyama, Hiroshima 729‑0292, Japan.
Department of Pharmacology, Osaka Metropolitan University Graduate School of Medicine, Osaka 558‑8585, Japan.
Mol Med Rep. 2023 Nov;28(5). doi: 10.3892/mmr.2023.13103. Epub 2023 Sep 29.
Glutathione‑specific γ‑glutamylcyclotransferase 1 (), is an unfolded protein response‑induced gene. Although it has been previously reported that transcription is regulated by activating transcription factor (ATF) 4, ATF3 and CCAAT/enhancer‑binding protein β (C/EBPβ), the signaling pathways that regulate CHAC1 are largely unknown. It was revealed that 3‑(5'‑hydroxymethyl‑2'‑furyl)‑1‑benzylindazole (YC‑1; PubChem ID: 5712), a nitric oxide‑independent activator of soluble guanylyl cyclase (sGC), increases CHAC1 levels in cultured human kidney proximal tubular cells (HK‑2). Therefore, in the present study, the signaling pathways that induce CHAC1 by YC‑1 were investigated in HK‑2 cells. YC‑1 induced CHAC1 expression in a dose‑ and time‑dependent manner. KT5823, an inhibitor of cGMP‑dependent protein kinase (PKG), partially inhibited CHAC1 upregulation, indicating that the sGC‑cGMP‑PKG pathway participates in CHAC1 regulation. These results also suggested that other signaling pathways are involved in the regulation of CHAC1. Since antibody array analysis showed the activation of p38, mTOR and Akt, the involvement of these factors was further investigated. Although LY294002 and KU0063794 (inhibitors of Akt and mTOR, respectively) inhibited YC‑1‑induced CHAC1 expression, SB203580 (an inhibitor of p38) did not. These results indicated that CHAC1 is regulated by the Akt‑mTOR pathway. In addition, YC‑1 induced endoplasmic reticulum (ER) stress, a regulator of CHAC1 induction. These findings suggested that CHAC1 is regulated by YC‑1 through the sGC‑cGMP‑PKG, Akt‑mTOR and ER stress pathways. The present study demonstrated that CHAC1 induction reduced the intracellular glutathione concentration, indicating that CHAC1 plays an important role in intracellular redox homeostasis in tubular cells.
谷胱甘肽特异性γ-谷氨酰环转移酶 1()是未折叠蛋白反应诱导的基因。虽然先前有报道称转录受激活转录因子(ATF)4、ATF3 和 CCAAT/增强子结合蛋白β(C/EBPβ)调节,但调节 CHAC1 的信号通路在很大程度上尚不清楚。研究表明,3-(5'-羟甲基-2'-呋喃基)-1-苯并吲哚(YC-1;PubChem ID:5712),一种非一氧化氮依赖性可溶性鸟苷酸环化酶(sGC)激活剂,可增加培养的人肾近端小管细胞(HK-2)中的 CHAC1 水平。因此,在本研究中,研究了 YC-1 通过 HK-2 细胞诱导 CHAC1 的信号通路。YC-1 呈剂量和时间依赖性诱导 CHAC1 表达。cGMP 依赖性蛋白激酶(PKG)抑制剂 KT5823 部分抑制 CHAC1 的上调,表明 sGC-cGMP-PKG 通路参与 CHAC1 调节。这些结果还表明其他信号通路也参与了 CHAC1 的调节。由于抗体阵列分析显示 p38、mTOR 和 Akt 的激活,进一步研究了这些因素的参与情况。虽然 LY294002 和 KU0063794(分别为 Akt 和 mTOR 的抑制剂)抑制了 YC-1 诱导的 CHAC1 表达,但 SB203580(一种 p38 抑制剂)没有。这些结果表明,CHAC1 受 Akt-mTOR 通路调节。此外,YC-1 诱导内质网(ER)应激,这是 CHAC1 诱导的调节剂。这些发现表明,CHAC1 受 YC-1 通过 sGC-cGMP-PKG、Akt-mTOR 和 ER 应激通路调节。本研究表明,CHAC1 的诱导降低了细胞内谷胱甘肽浓度,表明 CHAC1 在管状细胞的细胞内氧化还原平衡中发挥重要作用。